Naftidrofuryl oxalate is used for the treatment of cerebrovascular and peripheral vascular diseases; it acts as a vasodilator in peripheral and cerebral blood vessels, antagonizes the effects of serotonin (5-HT) and bradykinin, enhances cellular oxidative capacity, and provides protective effects against cellular hypoxia; it also exhibits papaverine-like spasmolytic activity that is slow in onset but long-lasting; it is effective in relieving muscle cramp pain and is considered the most effective and cost-effective vasoactive drug for peripheral arterial disease (PAD), significantly improving maximum walking distance (MWD) and pain-free walking distance (PFWD) in patients with claudication.